The leading annual meeting dedicated to biomarker research and implementation  



Conference Programs

Track 1: Biomarkers in Drug Development 

  • Biomarkers for drug safety assessment
  • Biomarkers in clinical trials
  • Translational biomarkers
  • Personalized medicine

Track 2: Molecular Diagnostics 

  • Biomarker assay development
  • Laboratory-developed tests
  • Next-generation "Omics" diagnostics

Track 3: Executive Summit: Drug-Diagnostic Co-Development 

  • Drug-diagnostic co-development case studies
  • Partnering strategies
  • Regulatory requirements for companion diagnostics

Plenary Keynotes

Felix Frueh Felix W. Frueh, Ph.D., President, Medco Research Institute, Medco Health Solutions, Inc.

Nicholas Dracopoli Nicholas C. Dracopoli, Ph.D., Vice President, Biomarkers, Centocor R&D, Johnson & Johnson

Geert Kolvenbag Geert Kolvenbag, M.D., Ph.D., Vice President,
Global Product, AstraZeneca



Pre-Conference Events:

Short Course: Fit-for-Purpose Biomarker Assay Development and Validation

New Company Showcase and Partnering Forum:
Next-Generation Biomarkers and Diagnostics



For more details on the conference, please contact: 
Julia BoguslavskyJulia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute

T: 760-732-3139
E: juliab@healthtech.com 

For exhibit & sponsorship opportunities, please contact: 
Ilana QuigleyIlana Quigley
Manager, Business Development
Cambridge Healthtech Institute

T: 781-972-5457
E: iquigley@healthtech.com

For media and association partnerships, please contact: 
Rich HandyRich Handy
Senior Director, Marketing
Cambridge Healthtech Institute

T: 781.972.5456
E: rhandy@healthtech.com